(5S)-N,2-dimethyl-N-[[(3R)-oxan-3-yl]methyl]-4,5,6,7-tetrahydro-3H-benzimidazole-5-carboxamide
C16H25N3O2 — CID 129393812
Data last refreshed: (MolForge compound catalog, from PubChem)
About (5S)-N,2-dimethyl-N-[[(3R)-oxan-3-yl]methyl]-4,5,6,7-tetrahydro-3H-benzimidazole-5-carboxamide
(5S)-N,2-dimethyl-N-[[(3R)-oxan-3-yl]methyl]-4,5,6,7-tetrahydro-3H-benzimidazole-5-carboxamide (PubChem CID 129393812) has the molecular formula C16H25N3O2 and a molecular weight of 291.39 g/mol. Its IUPAC name is (5S)-N,2-dimethyl-N-[[(3R)-oxan-3-yl]methyl]-4,5,6,7-tetrahydro-3H-benzimidazole-5-carboxamide.
Molecular Properties
| Compound Name | (5S)-N,2-dimethyl-N-[[(3R)-oxan-3-yl]methyl]-4,5,6,7-tetrahydro-3H-benzimidazole-5-carboxamide |
|---|---|
| PubChem CID | 129393812 |
| Molecular Formula | C16H25N3O2 |
| Molecular Weight | 291.39 g/mol |
| Exact Mass | 291.19 |
| IUPAC Name | (5S)-N,2-dimethyl-N-[[(3R)-oxan-3-yl]methyl]-4,5,6,7-tetrahydro-3H-benzimidazole-5-carboxamide |
| SMILES | Cc1nc2c([nH]1)C[C@@H](C(=O)N(C)C[C@H]1CCCOC1)CC2 |
| InChI | InChI=1S/C16H25N3O2/c1-11-17-14-6-5-13(8-15(14)18-11)16(20)19(2)9-12-4-3-7-21-10-12/h12-13H,3-10H2,1-2H3,(H,17,18)/t12-,13+/m1/s1 |
| InChIKey | WPMDFGLFVKBYIV-OLZOCXBDSA-N |
| XLogP | 1.71 |
| TPSA | 58.22 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 291.39 |
| LogP ≤ 5 | 1.71 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 129393812 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.